Barbara Malinowska
20d ago
medicinepharmacologypulmonary-hypertension
BackgroundPulmonary arterial hypertension (PAH) is a severe multifactorial disease associated with impaired pulmonary hemodynamics, leading to right ventricular (RV) hypertrophy and failure. Induction of inducible nitric oxide synthase (iNOS) and/or activation of cannabinoid CB1 receptor (CB1R) is associated with pro-inflammatory, pro-fibrotic, and pro-hypertrophic effects. Therefore, we tested t…
Dr. Stephen Chan’s care for one patient helped inspire a family-funded research effort to change the future of pulmonary hypertension.